Ian Woolhouse
YOU?
Author Swipe
View article: What Is the Accuracy of Clinical Staging for Stage III-Single-station N2 NSCLC? A Multi-Centre UK Study
What Is the Accuracy of Clinical Staging for Stage III-Single-station N2 NSCLC? A Multi-Centre UK Study Open
During multidisciplinary team discussions, clinicians must be aware that one-third of patients with stage III-ssN2 on the basis of CT, PET, and staging EBUS do not truly have ssN2 and this questions the use of this criterion to define trea…
View article: Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial) Open
Introduction Optimal treatment for 'potentially resectable' stage III-N2 non-small cell lung cancer (NSCLC) requires multimodality treatment: local treatment (surgery or radiotherapy) and systemic anticancer therapy.There is no clear evide…
View article: How to conduct a clinical audit in six steps
How to conduct a clinical audit in six steps Open
A guide
View article: Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial) Open
Introduction Optimal treatment for ‘potentially resectable’ stage III-N2 non-small cell lung cancer (NSCLC) requires multimodality treatment: local treatment (surgery or radiotherapy) and systemic anticancer therapy. There is no clear evid…
View article: Electronic prescribing systems as tools to improve patient care: A learning health systems approach to increase guideline concordant prescribing for venous thromboembolism prevention.
Electronic prescribing systems as tools to improve patient care: A learning health systems approach to increase guideline concordant prescribing for venous thromboembolism prevention. Open
Background Venous thromboembolism (VTE) causes significant mortality and morbidity in hospitalised patients. Risk factors for VTE are well known and there are validated risk assessment tools to support the use of prophylactic therapies. In…
View article: Electronic prescribing systems as tools to improve patient care: a learning health systems approach to increase guideline concordant prescribing for venous thromboembolism prevention
Electronic prescribing systems as tools to improve patient care: a learning health systems approach to increase guideline concordant prescribing for venous thromboembolism prevention Open
BACKGROUND Venous thromboembolism (VTE) causes significant mortality and morbidity in hospitalised patients. In England, reporting the percentage of patients with a completed VTE risk assessment is mandated, but this does not include wheth…
View article: Impact of organisation and specialist service delivery on lung cancer outcomes
Impact of organisation and specialist service delivery on lung cancer outcomes Open
Introduction Data from the National Lung Cancer Audit (NLCA) often show variation in outcomes between lung cancer units which are not entirely explained by case mix. We explore the association between the organisation of services and patie…
View article: British Thoracic Society quality standards for the investigation and management of pulmonary nodules
British Thoracic Society quality standards for the investigation and management of pulmonary nodules Open
Introduction The purpose of the quality standards document is to provide healthcare professionals, commissioners, service providers and patients with a guide to standards of care that should be met for the investigation and management of p…
View article: British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma Open
Section 3: Clinical features which predict the presence of mesothelioma Recommendations Section 4: Staging systems Recommendation Section 5: Imaging modalities for diagnosing and staging Recommendations Section 6: Pathological diagnosis Re…
View article: Introducing the new BTS guideline: the investigation and management of pleural malignant mesothelioma
Introducing the new BTS guideline: the investigation and management of pleural malignant mesothelioma Open
Active symptom control AUC Area under the curve
View article: BTS guideline for the investigation and management of malignant pleural mesothelioma
BTS guideline for the investigation and management of malignant pleural mesothelioma Open
The full guideline for the investigation and management of malignant pleural mesothelioma is published in Thorax . The following is a summary of the recommendations and good practice points. The sections referred to in the summary refer to…
View article: S98 Treatment patterns and survival outcomes of stage iiia (n2) non -small cell lung cancer in england
S98 Treatment patterns and survival outcomes of stage iiia (n2) non -small cell lung cancer in england Open
Introduction The optimal management of lung cancer patients with metastatic involvement of the ipsilateral mediastinum (N2 disease) remains controversial. Randomised controlled trials have failed to demonstrate superiority of one bimodalit…
View article: S100 Utility of endobronchial ultrasound-guided transbronchial needle aspiration for pd-l1 testing in patients with nsclc
S100 Utility of endobronchial ultrasound-guided transbronchial needle aspiration for pd-l1 testing in patients with nsclc Open
Rationale Recent data have demonstrated the superiority of Pembroluzimab over chemotherapy for patients with advanced NSCLC and high (≥50% expression) of PD-L1.1 This has resulted in NICE approving Pembroluzimab as a first line treatment o…
View article: Apples and pears? A comparison of two sources of national lung cancer audit data in England
Apples and pears? A comparison of two sources of national lung cancer audit data in England Open
In 2014, the method of data collection from NHS trusts in England for the National Lung Cancer Audit (NLCA) was changed from a bespoke dataset called LUCADA (Lung Cancer Data). Under the new contract, data are submitted via the Cancer Outc…
View article: S60 Lung cancer surgical survival and volume in england
S60 Lung cancer surgical survival and volume in england Open
Introduction The National Lung Cancer Audit has collected data for over 10 years demonstrating gradually rising resection rates in the UK. The Clinical (formerly Consultant) Outcomes Programme (COP) is an NHS England initiative, managed by…
View article: P103 Apples and pears? a comparison of two sources of lung cancer data in england
P103 Apples and pears? a comparison of two sources of lung cancer data in england Open
Introduction In 2014, the contract to deliver the National Lung Cancer Audit (NLCA) was awarded to the Royal College of Physicians. Data were previously submitted using a bespoke dataset (LUCADA), but will now be submitted via the national…
View article: P104 Results of the first analysis of national lung cancer audit data based on cancer registration data
P104 Results of the first analysis of national lung cancer audit data based on cancer registration data Open
Introduction The National Lung Cancer Audit (NLCA) has collected data for over 10 years, but in early 2015 a transition to using the Cancer Outcomes and Services Dataset (COSD) and cancer registration was begun and has now entirely superse…
View article: Patient characteristics, treatment and survival in pulmonary carcinoid tumours: an analysis from the UK National Lung Cancer Audit
Patient characteristics, treatment and survival in pulmonary carcinoid tumours: an analysis from the UK National Lung Cancer Audit Open
Objectives Pulmonary carcinoid (PC) is a rare tumour with good prognosis following surgical resection. However, little is known regarding patient characteristics and use of other treatments modalities. Our objective was to review patient c…